Páramo JA - Search Results

1

Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?

Páramo JA, Rodríguez JA, Beloqui O, Orbe J. Páramo JA, et al. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):303-11. doi: 10.2174/1568006054553381. Curr Drug Targets Cardiovasc Haematol Disord. 2005. PMID: 16101563 Review.

2

Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

Orbe J, Beloqui O, Rodriguez JA, Belzunce MS, Roncal C, Páramo JA. Orbe J, et al. Among authors: paramo ja. Clin Chim Acta. 2006 Jun;368(1-2):138-43. doi: 10.1016/j.cca.2005.12.019. Epub 2006 Feb 3. Clin Chim Acta. 2006. PMID: 16458279 Free article.

3

Vulnerable plaque versus vulnerable patient: emerging blood biomarkers for risk stratification.

Páramo JA, Rodríguez JA, Orbe J. Páramo JA, et al. Endocr Metab Immune Disord Drug Targets. 2007 Sep;7(3):195-201. doi: 10.2174/187153007781662558. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17897046 Review.

4

[Atheroma plaque stabilization: a new concept based on the dynamic biology of atherosclerosis].

Páramo JA, Orbe J, Rodríguez JA. Páramo JA, et al. Med Clin (Barc). 2003 Nov 1;121(15):583-7. doi: 10.1016/s0025-7753(03)74022-6. Med Clin (Barc). 2003. PMID: 14622526 Review. Spanish.

5

Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

Beloqui O, Páramo JA, Orbe J, Benito A, Colina I, Monasterio A, Díez J. Beloqui O, et al. Among authors: paramo ja. Eur Heart J. 2005 Jan;26(2):153-8. doi: 10.1093/eurheartj/ehi016. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618071

6

[Fibrinogen. An old hemostatic protein with a new function: non-invasive marker of subclinical atherosclerosis].

Páramo JA, Rodríguez JA, Orbe J. Páramo JA, et al. Med Clin (Barc). 2005 May 28;124(20):790-4. doi: 10.1157/13075852. Med Clin (Barc). 2005. PMID: 15927107 Review. Spanish.

7

[Cyclooxygenase-2: a new therapeutic target in atherosclerosis?].

Páramo JA, Beloqui O, Orbe J. Páramo JA, et al. Med Clin (Barc). 2006 May 27;126(20):782-6. doi: 10.1157/13089104. Med Clin (Barc). 2006. PMID: 16792983 Review. Spanish.

8

[Atherosclerosis in inflammatory diseases].

Páramo JA, Rodríguez JA, Orbe J. Páramo JA, et al. Med Clin (Barc). 2007 May 19;128(19):749-56. doi: 10.1157/13106130. Med Clin (Barc). 2007. PMID: 17565884 Review. Spanish.

9

Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.

Zalba G, Fortuño A, Orbe J, San José G, Moreno MU, Belzunce M, Rodríguez JA, Beloqui O, Páramo JA, Díez J. Zalba G, et al. Among authors: paramo ja. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):587-93. doi: 10.1161/01.ATV.0000256467.25384.c6. Epub 2006 Dec 28. Arterioscler Thromb Vasc Biol. 2007. PMID: 17194891 Free article.

10

Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty.

Orbe J, Rodriguez JA, Calvo A, Grau A, Belzunce MS, Martinez-Caro D, Páramo JA. Orbe J, et al. Among authors: paramo ja. Cardiovasc Res. 2001 Feb 1;49(2):484-92. doi: 10.1016/s0008-6363(00)00260-1. Cardiovasc Res. 2001. PMID: 11164859 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters